From fibroblasts to iPS cells: Induced pluripotency by defined factors
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Patient‐specific pluripotent cells may serve as a limitless source of transplantable tissue to treat a number of human blood and degenerative diseases without causing immune rejection. Recently, isolation of patient‐specific induced pluripotent stem (iPS) cells was achieved by transducing fibroblasts with four transcription factors, Oct4, Sox2, Klf4, and c‐Myc. However, the use of oncogenes and retrovirus in the current iPS cell establishment protocol raises safety concerns. To generate clinical quality iPS cells, the development of novel reprogramming methods that avoid permanent genetic modification is highly desired. The molecular mechanisms that mediate reprogramming are essentially unknown. We argue that establishment of a stable and self‐sustainable ES‐specific transcriptional regulatory network is essential for reprogramming. Such a system should include expression of Oct4, Sox2, Nanog and probably other pluripotenty‐promoting factors from endogenous loci and establishment of a permissive epigenetic state to maintain such expression. In addition, though not yet proven experimentally, overcoming cellular senescence of fibroblasts by inactivating Rb and p53 pathways and up‐regulating telomerase activity may also be required. J. Cell. Biochem. 105: 949–955, 2008. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Generation of human induced pluripotent stem cells from dermal fibroblasts
Lowry, W. E., Richter, L., Yachechko, R., Pyle, A. D., Tchieu, J., Sridharan, R., Clark, A. T., & Plath, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711983105 · Cited by 1,041 · cited 1×
“Recently, a growing number of groups have succeeded in deriving human iPS cells, proving that the technique is robust [Lowry et al., 2008; Mali et al., 2008; Masaki et al., 2008].”
Direct activation of TERT transcription by c-MYC
Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R. (1999) · Nature Genetics · doi:10.1038/6010 · Cited by 893
Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse
Stadtfeld, M., Maherali, N., Breault, D. T., & Hochedlinger, K. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.02.001 · Cited by 823 · cited 9×
“…and Nanog are known to bind to their own promoters and up-regulate gene expression [Boyer et al., 2005; Loh et al., 2006], activation of the endogenous loci of these genes only JOURNAL OF CELLULAR BIOCHEMISTRY comes at later stages of reprogramming [Brambrink et al., 2008; Stadtfeld et al., 2008].”
BackgroundInfluentialCharacterization of Dicer-deficient murine embryonic stem cells
Murchison, E. P., Partridge, J. F., Tam, O. H., Cheloufi, S., & Hannon, G. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505479102 · Cited by 800
The two-stage mechanism controlling cellular senescence and immortalization
Wright, W. E., & Shay, J. W. (1992) · Experimental Gerontology · doi:10.1016/0531-5565(92)90069-c · Cited by 383
Mali, P., Ye, Z., Hommond, H. H., Yu, X., Lin, J., Chen, G., Zou, J., & Cheng, L. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0346 · Cited by 291 · cited 2×
“Recently, a growing number of groups have succeeded in deriving human iPS cells, proving that the technique is robust [Lowry et al., 2008; Mali et al., 2008; Masaki et al., 2008].”
Background
Cited by
Samavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.-K., Beyer, T. A., Datti, A., Woltjen, K., Nagy, A., & Wrana, J. L. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.015 · Cited by 943
KLF Family Members Regulate Intrinsic Axon Regeneration Ability
Moore, D. L., Blackmore, M. G., Hu, Y., Kaestner, K. H., Bixby, J. L., Lemmon, V. P., & Goldberg, J. L. (2009) · Science · doi:10.1126/science.1175737 · Cited by 714
Complexity of dopamine metabolism
Meiser, J., Weindl, D., & Hiller, K. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-34 · Cited by 663
Two Supporting Factors Greatly Improve the Efficiency of Human iPSC Generation
Zhao, Y., Yin, X., Qin, H., Zhu, F., Liu, H., Yang, W., Zhang, Q., Xiang, C., Hou, P., Song, Z., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.10.002 · Cited by 468
“Our results, together with other related reports (Mali et al., 2008; Qin et al., 2007; Zhao and Daley, 2008), suggest that cellular senescence may act as a barrier for the generation of iPSCs. p53 siRNA may also function as an antagonist of cellular apoptosis and consequently contribute to the…”
ResultTelomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells
Marion, R. M., Strati, K., Li, H., Tejera, A., Schoeftner, S., Ortega, S., Serrano, M., & Blasco, M. A. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2008.12.010 · Cited by 461
Radiation‐Induced Reprogramming of Breast Cancer Cells
Lagadec, C., Vlashi, E., Della Donna, L., Dekmezian, C., & Pajonk, F. (2012) · STEM CELLS · doi:10.1002/stem.1058 · Cited by 401
The Cell Cycle and Myc Intersect with Mechanisms that Regulate Pluripotency and Reprogramming
Singh, A. M., & Dalton, S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.07.003 · Cited by 275
Stem Cell Therapy for Vascular Regeneration: Adult, Embryonic, and Induced Pluripotent Stem Cells
Leeper, N. J., Hunter, A. L., & Cooke, J. P. (2010) · Circulation · doi:10.1161/circulationaha.109.881441 · Cited by 195
Feeder-free self-renewal of human embryonic stem cells in 3D porous natural polymer scaffolds
Li, Z., Leung, M., Hopper, R., Ellenbogen, R., & Zhang, M. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.070 · Cited by 160
Wang, G., Badylak, S. F., Heber-Katz, E., Braunhut, S. J., & Gudas, L. J. (2010) · Regenerative Medicine · doi:10.2217/rme.09.91 · Cited by 35
Metadata
- Authors
- Zhao, R., & Daley, G. Q.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2008-07-30
- Volume
- 105
- Issue
- 4
- Pages
- 949-955
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2164012688
- Cited by
- 106
- References
- 7
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.